Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Milroy

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2005
Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancerJ Brown, H Thorpe, V Napp, et al.
British Journal of Cancer|August 17, 2000
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung CancerH Anderson, P Hopwood, R J Stephens, et al.
Thorax|September 30, 2004
Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of lifeS G Spiro, R M Rudd, R L Souhami, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2005
Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancerJ Brown, H Thorpe, V Napp, et al.
British Journal of Cancer|August 17, 2000
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung CancerH Anderson, P Hopwood, R J Stephens, et al.
Thorax|September 30, 2004
Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of lifeS G Spiro, R M Rudd, R L Souhami, et al.
Pageof 7